Aarti Drugs Limited (NSE:AARTIDRUGS)
India · Delayed Price · Currency is INR 378.40
+12.50 (3.42%)
May 19, 2026, 3:29 PM IST
Aarti Drugs Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 1,949 | 1,682 | 1,714 | 1,663 | 2,050 |
Depreciation & Amortization | 669.7 | 541.94 | 510.48 | 501.28 | 500.08 |
Other Amortization | - | 15.83 | 3.99 | 1.96 | 0.41 |
Loss (Gain) From Sale of Assets | - | -0.3 | 1.83 | -1.11 | -0.17 |
Asset Writedown & Restructuring Costs | - | 12.32 | - | - | - |
Loss (Gain) From Sale of Investments | 0.5 | -2.71 | 2.92 | - | - |
Provision & Write-off of Bad Debts | 36.6 | 37.22 | 18.96 | 7.59 | 16.87 |
Other Operating Activities | 521.6 | 124.08 | 309.02 | 323.77 | 10.09 |
Change in Accounts Receivable | -700 | 343.5 | 1,611 | -944.22 | -1,939 |
Change in Inventory | -178.5 | 129.64 | 342.46 | 58.22 | -1,106 |
Change in Accounts Payable | 236.3 | -437.26 | -925.31 | -277.37 | 1,171 |
Operating Cash Flow | 2,535 | 2,446 | 3,589 | 1,333 | 704.14 |
Operating Cash Flow Growth | 3.66% | -31.86% | 169.22% | 89.34% | -54.56% |
Capital Expenditures | -1,733 | -1,772 | -2,263 | -1,648 | -1,520 |
Sale of Property, Plant & Equipment | 2.8 | 0.48 | 1.87 | 1.45 | 0.2 |
Investment in Securities | -15.3 | 2.71 | - | - | - |
Other Investing Activities | 11.6 | 122.12 | 24.97 | 7 | 23.15 |
Investing Cash Flow | -1,734 | -1,646 | -2,237 | -1,640 | -1,496 |
Short-Term Debt Issued | - | 409.24 | - | 13.97 | 2,028 |
Long-Term Debt Issued | 430.3 | 702.4 | 1,482 | 1,158 | - |
Total Debt Issued | 430.3 | 1,112 | 1,482 | 1,172 | 2,028 |
Short-Term Debt Repaid | -132.3 | - | -1,245 | - | - |
Long-Term Debt Repaid | -567.8 | -776.08 | -459.36 | -558.61 | -68.69 |
Total Debt Repaid | -700.1 | -776.08 | -1,705 | -558.61 | -68.69 |
Net Debt Issued (Repaid) | -269.8 | 335.56 | -222.85 | 613.74 | 1,959 |
Issuance of Common Stock | - | - | - | 7.56 | - |
Repurchase of Common Stock | - | -731.73 | -731.73 | - | -738.38 |
Common Dividends Paid | -181.7 | -90.61 | -92.67 | -94.01 | -95.08 |
Other Financing Activities | -322.9 | -334.41 | -313.08 | -361.86 | -205.78 |
Financing Cash Flow | -774.4 | -821.19 | -1,360 | 165.42 | 920.25 |
Miscellaneous Cash Flow Adjustments | - | 0 | - | - | -0 |
Net Cash Flow | 26.9 | -21.65 | -7.61 | -141.09 | 127.99 |
Free Cash Flow | 802.2 | 674.22 | 1,326 | -314.97 | -815.61 |
Free Cash Flow Growth | 18.98% | -49.15% | - | - | - |
Free Cash Flow Margin | 3.12% | 2.83% | 5.24% | -1.16% | -3.28% |
Free Cash Flow Per Share | 8.79 | 7.39 | 14.42 | -3.40 | -8.81 |
Cash Interest Paid | - | 334.4 | 313.08 | 361.86 | 205.79 |
Cash Income Tax Paid | - | 551.17 | 624 | 596.75 | 833.77 |
Levered Free Cash Flow | -60.06 | -150.24 | 1,028 | -802.36 | -1,169 |
Unlevered Free Cash Flow | 150.63 | 73.96 | 1,237 | -594.28 | -1,040 |
Change in Working Capital | -642.2 | 35.88 | 1,028 | -1,163 | -1,874 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.